» Authors » Michael J Clemente

Michael J Clemente

Explore the profile of Michael J Clemente including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 1543
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Webster S, Les S, Deleon N, Heck D, Tsuj N, Clemente M, et al.
Immun Ageing . 2025 Feb; 22(1):9. PMID: 39994686
Background: Maintenance of the retina, part of the central nervous system, and other structures in the eye is critical for vision preservation. Aging increases the prevalence of vision impairment, including...
2.
Asosingh K, Bayiyana A, Black M, Chakraborty U, Clemente M, Graham A, et al.
Cytometry A . 2024 Aug; 105(9):704-712. PMID: 39095958
This "Best Practices in User Consultation" article is the result of a 2022 International Society for the Advancement of Cytometry (ISAC) membership survey that collected valuable insights from the shared...
3.
Webster S, Tsuji N, Clemente M, Holodick N
Front Immunol . 2023 Jan; 13:1047297. PMID: 36713434
Introduction: Natural antibody (NAb) derived from CD5+ B-1 cells maintains tissue homeostasis, controls inflammation, aids in establishing long-term protective responses against pathogens, and provides immediate protection from infection. CD5+ B-1...
4.
Webster S, Ryali B, Clemente M, Tsuji N, Holodick N
J Immunol . 2022 Mar; 208(7):1755-1771. PMID: 35256511
Natural Abs are primarily produced by B-1 cells and are essential for protection against The incidence and mortality rate for pneumococcal infection increases dramatically after age 65, disproportionately affecting males...
5.
Kerr C, Clemente M, Chomczynski P, Przychodzen B, Nagata Y, Adema V, et al.
Blood Adv . 2019 Mar; 3(6):917-921. PMID: 30898763
T large granular lymphocyte leukemia (T-LGLL) is a clonal lymphoproliferative disorder that can arise in the context of pathologic or physiologic cytotoxic T-cell (CTL) responses. mutations are often absent in...
6.
Clemente M, Przychodzen B, Hirsch C, Nagata Y, Bat T, Wlodarski M, et al.
Leukemia . 2018 May; 32(11):2507-2511. PMID: 29749402
No abstract available.
7.
Negoro E, Nagata Y, Clemente M, Hosono N, Shen W, Nazha A, et al.
Blood . 2017 Sep; 130(17):1953-1957. PMID: 28893734
No abstract available.
8.
Sanikommu S, Clemente M, Chomczynski P, Afable 2nd M, Jerez A, Thota S, et al.
Leuk Lymphoma . 2017 Jun; 59(2):416-422. PMID: 28633612
Large granular lymphocytic leukemia (LGLL) represents a clonal/oligoclonal lymphoproliferation of cytotoxic T and natural killer cells often associated with STAT3 mutations. When symptomatic, due to mostly anemia and neutropenia, therapy...
9.
Hirsch C, Przychodzen B, Radivoyevitch T, Patel B, Thota S, Clemente M, et al.
Haematologica . 2017 Mar; 102(6):1028-1034. PMID: 28255022
Myelodysplastic syndromes are typically diseases of older adults. Patients in whom the onset is early may have distinct molecular and clinical features or reflect a demographic continuum. The identification of...
10.
Hosono N, Makishima H, Mahfouz R, Przychodzen B, Yoshida K, Jerez A, et al.
Oncotarget . 2016 Dec; 8(4):6483-6495. PMID: 28031539
Background: Deletion of chromosome 5q (del(5q)) is the most common karyotypic abnormality in myeloid neoplasms. Materials And Methods: To define the pathogenic molecular features associated with del(5q), next-generation sequencing was...